Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04375722 · ClinicalTrials.gov registry record · NA

Transcranial Alternating Current Stimulation (tACS) in Aphasia

A NA study of Stroke and Aphasia, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04375722: Recruiting NA study of Stroke and Aphasia, sponsored by Medical College of Wisconsin.

NCT04375722 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04375722, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language functions.

Primary Outcome

Improvement on verbal STM performance as determined by increases in span, accuracy or decreases in reaction time is expected with active tACS.

Conditions Studied

Interventions

  • DEVICE tACS

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-01-04
Est. Completion 2030-12
Phase NA
Medical College of Wisconsin

447 total trials

What NCT04375722 shows while recruiting

NCT04375722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which tACS is the first listed.

NCT04375722 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04375722 about?

NCT04375722 is a clinical study titled "Transcranial Alternating Current Stimulation (tACS) in Aphasia". This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language functions.

What is the current status of trial NCT04375722?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-01-04. Estimated completion is 2030-12.

What conditions does trial NCT04375722 study?

This clinical trial studies the following conditions: Stroke, Aphasia.

What interventions are being tested in trial NCT04375722?

The interventions under investigation include: tACS (DEVICE).

Who is sponsoring clinical trial NCT04375722?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04375722 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04375722's enrollment target sits among peer trials

50 232nd of 454 higher than 209 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04375722, the US trial registry maintained by the National Library of Medicine. NCT04375722 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.